guardianship 发表于 2025-3-26 21:00:08

Epidermal Growth Factor (EGF) Receptor Kinase Activity is Required for Tumor Necrosis Factor (TNF)-αs required for TNF mediated transactivation of EGFR, ErbB2 and 4 through Src kinase activity and cell survival. Like as Src kinase inhibitor, PI 3-kinase inhibitor enhanced TNF-induced apoptosis, but not MAP kinase inhibitor. From the present study we postulate that EGFR and EGFR tyrosine kinase inv

Adenoma 发表于 2025-3-27 04:22:20

A Molecular Mechanism of Diminished Binding Activity between 15 bp Deletion Mutant EGFR and c-Cbl Ubtants. As the results, 1) the mutations of Y700F and Y73IF but Y774F reduced binding of wild type EGFR and c-Cbl. 2) all the three mutant c-Cbls showed less binding activity to the mutant EGFR. From these observations, it was suggested that the alteration of substrate specificity for c-Cbl and confo

cravat 发表于 2025-3-27 08:09:30

http://reply.papertrans.cn/67/6661/666033/666033_33.png

acrimony 发表于 2025-3-27 09:32:57

Role of MT1-MMP in Tumor-Stromal Interactions a tumor-derived mediator to induce MMP-2 expression in fibroblasts after cleaved by MT1-MMP. MT1-MMP cleaves EMMPRIN and released a 22 kDa fragment which has activity to augment expression of MMP-2 in fibropbrasts. Thus, there is a positive feedback loop between the MTl-MMP/MMP-2-dependent tumor g

清晰 发表于 2025-3-27 14:24:08

http://reply.papertrans.cn/67/6661/666033/666033_35.png

Fortuitous 发表于 2025-3-27 18:27:41

http://reply.papertrans.cn/67/6661/666033/666033_36.png

Efflorescent 发表于 2025-3-28 01:27:31

http://reply.papertrans.cn/67/6661/666033/666033_37.png

Flu表流动 发表于 2025-3-28 04:06:39

Drug Accumulation and Efflux Do not Contribute to Acquired Gefitinib Resistancen, cells were lysed and the radioactivities were counted. There was no significant difference of gefitinib accumulation in those cell lines (range 642–731 µmol/g protein at 30 min). The efficiencies of gefitinib-efflux were almost the same in those cell lines (about 80% of gefitinb was discharged at

合唱队 发表于 2025-3-28 09:47:33

Difference of EGFR-Binding Proteins between Wild Type and Mutant EGFRing. Much binding of HSP 70 to mutant EGFR was also confirmed by Western blotting. There was no significant difference of HSP 70 protein expression between both transfectant cells. These results suggest that the difference of HSP70 binding to EGFR may modify the EGFR-downstream signaling and influen

adj忧郁的 发表于 2025-3-28 13:58:15

http://reply.papertrans.cn/67/6661/666033/666033_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: New Trends in the Molecular and Biological Basis for Clinical Oncology; Tetsuhiko Tachikawa (Professor and Chairman),Kiyos Conference proc